mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for HEXB
Gene summary
Basic gene Info.Gene symbolHEXB
Gene namehexosaminidase B (beta polypeptide)
SynonymsENC-1AS|HEL-248
CytomapUCSC genome browser: 5q13
Type of geneprotein-coding
RefGenesNM_000521.3,
NM_001292004.1,
DescriptionHCC-7N-acetyl-beta-glucosaminidase subunit betabeta-N-acetylhexosaminidase subunit betabeta-hexosaminidase subunit betacervical cancer proto-oncogene 7 proteinepididymis luminal protein 248hexosaminidase subunit B
Modification date20141207
dbXrefs MIM : 606873
HGNC : HGNC
Ensembl : ENSG00000049860
HPRD : 06043
Vega : OTTHUMG00000102057
ProteinUniProt: P07686
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_HEXB
BioGPS: 3074
PathwayNCI Pathway Interaction Database: HEXB
KEGG: HEXB
REACTOME: HEXB
Pathway Commons: HEXB
ContextiHOP: HEXB
ligand binding site mutation search in PubMed: HEXB
UCL Cancer Institute: HEXB
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for HEXB
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
M65M65IBLCA1
W405E407QBLCA1
N190N190DUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for HEXB
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
W405E407Q-1.6080332
N190N190D-0.5299242
M65M65I-0.3862447
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for HEXB from PDB

Top
Differential gene expression and gene-gene network for HEXB
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of HEXB and the right PPI network was created from samples without mutations in the LBS of HEXB. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for HEXB
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0036161Sandhoff Disease35Biomarker, GeneticVariation
umls:C0751490Infantile Sandhoff Disease2Biomarker, GeneticVariation
umls:C2609414Acute Kidney Injury1Biomarker
umls:C0017661Glomerulonephritis, IGA1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for HEXB
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ExperimentalDB028132-Acetamido-2-Deoxy-D-Glucono-1,5-LactoneSmall molecule
ExperimentalDB037473ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-DiolSmall molecule
ExperimentalDB03861(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-PiperidiniumSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of HEXB go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE1nouAM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE1nouBM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE1nowAM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE1nowBM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE1np0AM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE1np0BM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gjxCM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gjxFM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gjxGM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gk1BM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gk1DM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gk1FM65 N190
NAGALDEHYDO-N-ACETYL-D-GLUCOSAMINE2gk1HM65 N190
NDGN-ACETYL-L-GLUTAMATE(2-)2gjxBN190
IFG(2R,3R,4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5-HYDROXYMETHYL-PIPERIDINE1nowAW405
IFG(2R,3R,4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5-HYDROXYMETHYL-PIPERIDINE1nowBW405
NGT3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL1np0AW405
NGT3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL1np0BW405
GDL2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE1o7aAW405
GDL2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE1o7aBW405
GDL2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE1o7aCW405
GDL2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE1o7aDW405
GDL2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE1o7aEW405
GDL2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE1o7aFW405
NGT3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL2gk1BW405
NGT3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL2gk1DW405
CP6PYRIMETHAMINE3lmyBW405


Top
Conservation information for LBS of HEXB
Multiple alignments for P07686 in multiple species
LBSAA sequence# speciesSpecies
D240HWHIVDDQSFP3Homo sapiens, Mus musculus, Rattus norvegicus
D240HWHIVDEQSFP1Arabidopsis thaliana
D240HWHLVDSESFP1Caenorhabditis elegans
D354IHLGGDEVE--3Homo sapiens, Mus musculus, Rattus norvegicus
D354FHLGGDEVN--1Arabidopsis thaliana
D354LHLGGDEVSDY1Caenorhabditis elegans
D452--WYLDLISYG3Homo sapiens, Mus musculus, Rattus norvegicus
D452GYWYLDHLD--1Arabidopsis thaliana
D452--WYLNYIKYG1Caenorhabditis elegans
E355HLGGDEVE---3Homo sapiens, Mus musculus, Rattus norvegicus
E355HLGGDEVN---1Arabidopsis thaliana
E355HLGGDEVSDYI1Caenorhabditis elegans
E491ACLWGEYVDAT2Homo sapiens, Rattus norvegicus
E491VCMWGETADTS1Arabidopsis thaliana
E491AAIWGELVDNT1Caenorhabditis elegans
E491ACLWGEFVDAT1Mus musculus
H237NVLHWHIVDDQ3Homo sapiens, Mus musculus, Rattus norvegicus
H237NVLHWHIVDEQ1Arabidopsis thaliana
H237NVLHWHLVDSE1Caenorhabditis elegans
H294FDTPGHTLSWG1Homo sapiens
H294VDVPGHAESWG1Arabidopsis thaliana
H294FDLPGHTSSW-1Caenorhabditis elegans
H294FDTPGHTQSWG1Mus musculus
H294FDSPGHTQSWG1Rattus norvegicus
L453-WYLDLISYGQ3Homo sapiens, Mus musculus, Rattus norvegicus
L453YWYLDHLD--V1Arabidopsis thaliana
L453-WYLNYIKYGA1Caenorhabditis elegans
L69KMTPNLLHLAP1Homo sapiens
L69SFGNETLSVDP1Arabidopsis thaliana
L69VYGSKNRTITY1Caenorhabditis elegans
L69QMFPRLLYISA1Mus musculus
L69QVFPRLLYISP1Rattus norvegicus
M65PLSVKMTPNLL1Homo sapiens
M65PAEFSFGNETL1Arabidopsis thaliana
M65PKKIVYGSKNR1Caenorhabditis elegans
M65PRSVQMFPRLL1Mus musculus
M65PRSVQVFPRLL1Rattus norvegicus
N190GTFTINEST--2Homo sapiens, Rattus norvegicus
N190KSVQIYKAPWY1Arabidopsis thaliana
N190QEYQIRTVE--1Caenorhabditis elegans
N190GTFTINESS--1Mus musculus
P54SAKPGPALWPL1Homo sapiens
P54----PPYLWPL1Arabidopsis thaliana
P54---SVGGVWPL1Caenorhabditis elegans
P54----QPALWPF1Mus musculus
P54----QPALWPM1Rattus norvegicus
P67SVKMTPNLLHL1Homo sapiens
P67EFSFGNETLSV1Arabidopsis thaliana
P67KIVYGSKNRTI1Caenorhabditis elegans
P67SVQMFPRLLYI1Mus musculus
P67SVQVFPRLLYI1Rattus norvegicus
R211LIDTSRHYLPV2Homo sapiens, Rattus norvegicus
R211LIDTSRHYLPI1Arabidopsis thaliana
R211MIDSSRHFLSV1Caenorhabditis elegans
R211LIDTSRHFLPV1Mus musculus
T66LSVKMTPNLLH1Homo sapiens
T66AEFSFGNETLS1Arabidopsis thaliana
T66KKIVYGSKNRT1Caenorhabditis elegans
T66RSVQMFPRLLY1Mus musculus
T66RSVQVFPRLLY1Rattus norvegicus
W405KGSIVWQEVFD1Homo sapiens
W405WTPVNWEETFS1Arabidopsis thaliana
W405RKPIFWQEVFD1Caenorhabditis elegans
W405KNSIVWQEVFD1Mus musculus
W405KSSIVWQDVFD1Rattus norvegicus
W424TIVEVWKDSAY1Homo sapiens
W424TVIQNWLVSDI1Arabidopsis thaliana
W424AVIHIWKGNTH1Caenorhabditis elegans
W424TVVEVWKSEHY1Mus musculus
W424TVVEVWKSENY1Rattus norvegicus
W489GEACLWGEYVD2Homo sapiens, Rattus norvegicus
W489GEVCMWGETAD1Arabidopsis thaliana
W489GIAAIWGELVD1Caenorhabditis elegans
W489GEACLWGEFVD1Mus musculus
Y450AP--WYLDLIS3Homo sapiens, Mus musculus, Rattus norvegicus
Y450NQGYWYLDHLD1Arabidopsis thaliana
Y450AC--WYLNYIK1Caenorhabditis elegans


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas